chr1-211103486-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_172362.3(KCNH1):c.310+10G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.215 in 1,523,160 control chromosomes in the GnomAD database, including 37,378 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.19 ( 3037 hom., cov: 33)
Exomes 𝑓: 0.22 ( 34341 hom. )
Consequence
KCNH1
NM_172362.3 intron
NM_172362.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.639
Genes affected
KCNH1 (HGNC:6250): (potassium voltage-gated channel subfamily H member 1) Voltage-gated potassium (Kv) channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. This gene encodes a member of the potassium channel, voltage-gated, subfamily H. This member is a pore-forming (alpha) subunit of a voltage-gated non-inactivating delayed rectifier potassium channel. It is activated at the onset of myoblast differentiation. The gene is highly expressed in brain and in myoblasts. Overexpression of the gene may confer a growth advantage to cancer cells and favor tumor cell proliferation. Alternative splicing of this gene results in two transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.65).
BP6
Variant 1-211103486-C-T is Benign according to our data. Variant chr1-211103486-C-T is described in ClinVar as [Benign]. Clinvar id is 262807.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.227 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNH1 | NM_172362.3 | c.310+10G>A | intron_variant | ENST00000271751.10 | NP_758872.1 | |||
KCNH1 | NM_002238.4 | c.310+10G>A | intron_variant | NP_002229.1 | ||||
KCNH1 | XM_047419823.1 | c.310+10G>A | intron_variant | XP_047275779.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNH1 | ENST00000271751.10 | c.310+10G>A | intron_variant | 2 | NM_172362.3 | ENSP00000271751.4 | ||||
ENSG00000283952 | ENST00000638880.1 | c.130+10G>A | intron_variant | 5 | ENSP00000491750.1 |
Frequencies
GnomAD3 genomes AF: 0.192 AC: 29165AN: 152056Hom.: 3037 Cov.: 33
GnomAD3 genomes
AF:
AC:
29165
AN:
152056
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.189 AC: 46772AN: 247452Hom.: 4940 AF XY: 0.193 AC XY: 25807AN XY: 133712
GnomAD3 exomes
AF:
AC:
46772
AN:
247452
Hom.:
AF XY:
AC XY:
25807
AN XY:
133712
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.218 AC: 298787AN: 1370986Hom.: 34341 Cov.: 20 AF XY: 0.217 AC XY: 149011AN XY: 686952
GnomAD4 exome
AF:
AC:
298787
AN:
1370986
Hom.:
Cov.:
20
AF XY:
AC XY:
149011
AN XY:
686952
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.192 AC: 29171AN: 152174Hom.: 3037 Cov.: 33 AF XY: 0.191 AC XY: 14229AN XY: 74398
GnomAD4 genome
AF:
AC:
29171
AN:
152174
Hom.:
Cov.:
33
AF XY:
AC XY:
14229
AN XY:
74398
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
411
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 15, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at